Adjunctive mucolytic therapy in adult patients w/ abnormal or viscid mucous secretions in such conditions as chronic bronchopulmonary diseases eg, chronic emphysema & asthmatic bronchitis, TB, bronchiectasis, primary amyloidosis of the lung. Acute bronchopulmonary disease eg, pneumonia, bronchitis, trancheobronchitis.
Sputum viscosity reduction in childn aged ≥6 yr.